Pharmaceuticals, Biotechnology and Life Sciences
ZURICH–(BUSINESS WIRE)–Regulatory News: Vifor Pharma today announced that treatment of the first patient in their global phase-IIIb DIAMOND study has…
SAN FRANCISCO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/EHA24?src=hash" target="_blank"gt;#EHA24lt;/agt;–Imago BioSciences, Inc., a clinical-stage biotechnology company developing innovative treatments for myeloid diseases, today announced that…
– Vofatamab activates immune changes in immunologically cold tumors and in combination increases patient response rates – – Data from…
PharmaCyte Biotech Proceeding with GMP Production of Pancreatic Cancer Product After Successful Changes to Manufacturing Process
The KEYTRUDA breast cancer clinical development program encompassesseveral internal and external collaborative studies, including threeongoing registration-enabling studies in TNBC.
Quality-adjusted progression free survival (QA-PFS) andquality-adjusted time without cancer related symptoms or toxicity(Q-TWiST) demonstrate the benefit of Rubraca maintenance treatment overplacebo from a patient perspective
OTX-TP failed to meet primary endpoint but achieved statisticallysignificant reduction of intraocular pressure versus placebo at eight ofthe nine pre-specified time points
LEHI, Utah–(BUSINESS WIRE)–Frelii Inc. (OTCQB: FRLI) (“Frelii” or “the Company”) today announced that on May 20, 2019, it filed with…
SAN DIEGO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/guthealth?src=hash" target="_blank"gt;#guthealthlt;/agt;–Gemelli Biotech, in partnership with the Medically Associated Science and Technology (MAST) program at Cedars-Sinai, announced…
WASHINGTON–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/BIOWC19?src=hash" target="_blank"gt;#BIOWC19lt;/agt;–The Biotechnology Innovation Organization (BIO) today announced that former U.S. Department of Agriculture (USDA) Secretary and former…